Novo Nordisk A/S (NVO)

Novo Nordisk A/S (NVO $53.75)
- $53.75 P/E (TTM): 14.88X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $292.62)
- $292.62 P/E (TTM): 27.03X Cap: $159.60B
- View AMGN Profile
- View Questions on AMGN
Intuitive Surgical Inc. (ISRG $481.28)
- $481.28 P/E (TTM): 66.89X Cap: $172.16B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $206.57)
- $206.57 P/E (TTM): 88.33X Cap: $365.12B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $698.05)
- $698.05 P/E (TTM): 57.06X Cap: $663.68B
- View LLY Profile
- View Questions on LLY
Stryker Corporation (SYK $381.61)
- $381.61 P/E (TTM): 50.58X Cap: $146B
- View SYK Profile
- View Questions on SYK
Novo Nordisk A/S (NVO $53.75)
- $53.75 P/E (TTM): 14.88X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

Q: I sold a portion of my NVO holdings a while ago, and am not inclined to buy it back just now. What would you see as the best buy in the US healthcare sector these days; possibly as a compliment to NVO, but not necessarily?

Read Answer Asked by David on August 13, 2025

Novo Nordisk A/S (NVO $53.75)
- $53.75 P/E (TTM): 14.88X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

Q: What are your thoughts on the class action securities lawsuits filed against NVO, and on class action securities lawsuits in general? Specifically related to NVO, I understand there are two lawsuits alleging that NVO misled investors, one linked to the ~18% stock price drop on December 20, 2024, and a more recent claim linked to the ~21% drop on July 29, 2025. What are the typical chances of receiving a recovery, what might the recovery amount be (% of losses), and how long do these lawsuits usually take to resolve? As an NVO shareholder, should I sign up for the more recent lawsuit, if eligible?

Read Answer Asked by Colum on August 06, 2025

Novo Nordisk A/S (NVO $53.75)
- $53.75 P/E (TTM): 14.88X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

Q: Hi,

I am considering a position in novo nordisk (the CDR).

1) Is this a good investment?

2) I have an uneasy feeling about the hedged CDRs. Where do they make their money? Where is the retail investor getting exploited?

Cheers,
David

Read Answer Asked by D on August 05, 2025